Thomson Reuters, a famed brokerage firm, has a 52-week price target of $54.57 on Amedisys Inc (NASDAQ:AMED) shares. After analyzing various factors, EPS is predicted to come at $1.69 for the next fiscal and $N/A for underway quarterly period.
For good or for bad, the investment community depends on earnings as its chief metric. Stocks are assessed not only by their capability to increase financial earnings QoQ, but also by if they can beat or meet a consensus earnings projections. Like it or not, shareholders need to keep a close watch on consensus estimates in order to keep checks on how a stock is expected to perform.
When companies release their quarterly report, investors are looking not just for improvements over past performance, but also for how the reported results compare to analysts’ projections. If the firm surprises the street with better-than-expected numbers, the stock usually gains. On the contrary, disappointing report can cause the share price to tumble. Investors, with a little understanding of earnings surprises, can deal with share price fluctuation during quarterly earnings seasons.
Earnings surprises happen when a firm’s results differ from consensus estimates. How results measure up to analysts’ estimates are vital to the price of stocks.
The P/E ratio of Amedisys Inc (NASDAQ:AMED) stands at 42.62. The second element that analysts look at is Price/Earnings Growth ratio. Investors prefer stocks that have a lower PEG ratio. For Amedisys Inc, this ratio for impending 3-5 years is 1.11.
The technical analysis highpoints that Amedisys Inc current is trading $0.23 points away or +0.46% from 50-day moving average of $48.49. It is trading $-0.71 or -1.43% away 200-day moving average of $49.43.
The 52-week high of Amedisys Inc (NASDAQ:AMED) was $55.16 while lowest point was $31.16. If stock surges over $-6.44, it will record a 52-week high. On contrary, the decline of +56.35% will result in a 52-week low.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...